Home › Trial NCT03605719
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
- Trial IDNCT03605719
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorEmory University
- Enrollment23
- Start date2018-10-24
- ConditionsRecurrent Plasma Cell Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.